# An Adaptive Treatment Strategy for Adolescent Depression-Continuation

> **NCT02017535** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 15 (actual)

## Conditions studied

- Adolescent Depression

## Interventions

- **DRUG:** Fluoxetine
- **BEHAVIORAL:** Interpersonal Psychotherapy

## Key facts

- **NCT ID:** NCT02017535
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-10-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02017535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02017535, "An Adaptive Treatment Strategy for Adolescent Depression-Continuation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02017535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
